Effectiveness of Aspirin 80, Aspirin 325, Enoxaparin and Rivoroxaban in Prevention of Coagulopathy after Total Knee Arthroplasty
Phase 3
Recruiting
- Conditions
- osteoarthritis.Unilateral primary osteoarthritis of knee
- Registration Number
- IRCT20181128041784N1
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 124
Inclusion Criteria
Patients with definite diagnosis of osteoarthritis, rheumatoid arthritis or joint destruction
Patients are candidates for knee replacement because of pain and severe motor limitation
Exclusion Criteria
History of skin allergy, respiratory or allergic to aspirin
History of the use of anticoagulant and hemorrhagic diseases
History of malignancy
History of liver and kidney disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Deep vein Thrombosis. Timepoint: 1, 2 and 6 week. Method of measurement: Venous Doppler Ultrasonography.
- Secondary Outcome Measures
Name Time Method Pulmonary thromboembolic. Timepoint: 1, 2 and 6 week. Method of measurement: CT Angiography.